SOPHiA Genetics
(NASDAQ) SOPH
SOPHiA Genetics Financials at a Glance
Market Cap
$358.34M
Revenue (TTM)
$81.18M
Net Income (TTM)
-$80.94M
EPS (TTM)
-$1.18
P/E Ratio
-4.23
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.01
Volume
79,688
Open
$4.95
Price
$5.01
Volume
79,688
Open
$4.95
Previous Close
$5.00
Daily Range
$4.83 - $5.06
52-Week Range
$2.59 - $5.70
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.01
Volume
79,688
Open
$4.95
Previous Close
$5.00
Daily Range
$4.83 - $5.06
52-Week Range
$2.59 - $5.70
Estimated Earnings Date
Aug 4, 2026
SOPH News
SOPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout SOPHiA Genetics
Industry
Health Care Technology
Sector
Health CareEmployees
415
CEO
Jurgi Camblong, PhD, EMBA
Website
www.sophiagenetics.comHeadquarters
Rolle, 1025, CH
SOPH Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-88%
Net Income Margin
-100%
Return on Equity
-123%
Return on Capital
-65%
Return on Assets
-52%
Earnings Yield
-23.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$358.34M
Shares Outstanding
71.67M
Volume
79.69K
Avg. Volume
95.46K
Financials (TTM)
Gross Profit
$47.81M
Operating Income
-$70.93M
EBITDA
-$61.40M
Operating Cash Flow
-$38.01M
Capital Expenditure
-$574.00K
Free Cash Flow
-$38.59M
Cash & ST Invst.
$70.29M
Total Debt
$63.02M
SOPHiA Genetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.69M
+22.0%
Gross Profit
$14.75M
+20.8%
Gross Margin
68.01%
N/A
Market Cap
$358.34M
N/A
Market Cap/Employee
$847.15K
N/A
Employees
423
N/A
Net Income
-$19.32M
-11.1%
EBITDA
-$14.53M
-4.4%
Quarterly Fundamentals
Net Cash
$2.97M
-92.3%
Accounts Receivable
$14.31M
+33.8%
Inventory
$7.09M
+40.3%
Long Term Debt
$59.71M
+114.5%
Short Term Debt
$2.71M
+18.6%
Return on Assets
-51.55%
N/A
Return on Invested Capital
-64.99%
N/A
Free Cash Flow
-$17.06M
-39.3%
Operating Cash Flow
-$16.18M
-50.5%